15 completed, 3 terminated, 2 recruiting. 6 Phase 2, 6 Phase 3, 5 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Recruiting 2, Terminated 1 |
| Phase 3 | 6 | Completed 4, Terminated 2 |
| Phase 1 | 5 | Completed 5 |
| Phase 4 | 1 | Completed 1 |
Follow Zanamivir: new trials by email Literature Review of Zanamivir trials Research Report on Zanamivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) Zanamivir, Placebo - Dengue Fever | Phase 2 | Recruiting | George Washington University | 74 | 2024-03-15 | 2026-07-29 |
| A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza Oseltamivir, Favipiravir, Zanamivir - Influenza, Influenza, Human | Phase 2 | Recruiting | University of Oxford | 3000 | 2023-02-22 | 2026-04-14 |
| An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection Zanamivir - Influenza, Human, Arthralgia | Phase 2 | Completed | GlaxoSmithKline | 8 | 2022-11-21 | 2026-07-28 |
| Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes Zanamivir - Diabetes Mellitus, Type 2 | Phase 2 | Completed | University of Missouri-Columbia | 14 | 2021-07-14 | 2025-04-25 |
| Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults Zanamivir - Influenza, Human | Phase 1 | Completed | GlaxoSmithKline | 24 | 2015-04-28 | 2017-05-09 |
| A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection Intravenous (IV) zanamivir - Influenza, Human | Phase 3 | Completed | GlaxoSmithKline | 21 | 2012-01-01 | 2018-02-22 |
| Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China Zanamivir, Placebo - Influenza A Virus Infection, Influenza B Virus Infection | Phase 3 | Completed | Jiangsu Simcere Pharmaceutical Co., Ltd. | 298 | 2011-10-01 | 2013-01-16 |
| Safety of Inhaled Zanamivir in Pregnancy Treatment with zanamivir - Influenza, Human | Completed | GlaxoSmithKline | 1 | 2011-07-01 | 2014-04-21 | |
| A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers 600 mg zanamivir + moxifloxacin placebo, 1200 mg zanamivir + moxifloxacin placebo, zanamivir placebo + moxifloxacin placebo - Influenza, Human | Phase 1 | Completed | GlaxoSmithKline | 40 | 2011-05-19 | 2017-07-21 |
| A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza Zanamivir, Placebo to match zanamivir, Oseltamivir - Influenza, Human | Phase 3 | Completed | GlaxoSmithKline | 626 | 2011-01-15 | 2018-10-15 |
| Relenza® Sentinel Site Monitoring Program in Japan zanamivir - Influenza, Human | Completed | GlaxoSmithKline | 1575 | 2009-11-01 | 2017-07-06 | |
| Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days Zanamivir - Influenza A Virus, H1N1 Subtype | Phase 1 | Completed | GlaxoSmithKline | 18 | 2009-10-12 | 2017-06-14 |
| A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection Oseltamivir, Zanamivir, Placebo of Oseltamivir - Upper Respiratory Tract Infection, Influenza | Phase 3 | Terminated | Chinese University of Hong Kong | 4 | 2009-10-01 | 2011-04-11 |
| Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir active oseltamivir, placebo capsule, zanamivir for inhalation - Influenza | Phase 4 | Completed | University of Oxford | 390 | 2009-09-01 | 2010-09-22 |
| Prophylactic Efficacy of Relenza Against Influenza A and B Receiving a prescription of Relenza for prophylaxis, No prophylaxis with Relenza - Pulmonary Disease, Chronic Obstructive, Bronchospasm | Completed | GlaxoSmithKline | 171705 | 2009-07-01 | 2017-05-30 | |
| Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults Zanamivir, Oseltamivir - Influenza, Virus Diseases | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 17 | 2009-07-01 | 2010-03-19 |
| TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients TCAD, Zanamivir or Oseltamivir, Open label treatment with TCAD - Influenza | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 7 | 2009-03-01 | 2013-08-15 |
| Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection oseltamivir + zanamivir, oseltamivir+ amantadine, oseltamivir - Influenza A Infection | Phase 2 | Terminated | Hospices Civils de Lyon | 60 | 2009-01-01 | 2010-09-30 |
| Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir oseltamivir + zanamivir, oseltamivir + zanamivir's placebo, oseltamivir's placebo + zanamivir - Gastric Influenza | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 541 | 2008-12-01 | 2012-03-19 |
| Zanamivir Versus Trivalent Split Virus Influenza Vaccine Fluviral, Zanamivir - Influenza | Phase 3 | Completed | Mount Sinai Hospital, Canada | 64 | 2008-11-01 | 2014-11-21 |
Influenza, Human (14) · Arthralgia (1) · Asthma (1) · Bronchial Spasm (1) · Bronchitis (1) · Dengue (1) · Diabetes Mellitus, Type 2 (1) · Orthomyxoviridae Infections (1) · Pneumonia (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Sinusitis (1) · Virus Diseases (1)
GlaxoSmithKline (9) · University of Oxford (2) · Assistance Publique - Hôpitaux de Paris (1) · Chinese University of Hong Kong (1) · Fred Hutchinson Cancer Center (1) · George Washington University (1) · Hospices Civils de Lyon (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Mount Sinai Hospital, Canada (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Missouri-Columbia (1)
United States (5) · China (4) · Thailand (4) · France (3) · Brazil (2) · Canada (2) · Colombia (2) · Hong Kong (2) · Poland (2) · Spain (2) · Australia (1) · Belgium (1) · Czechia (1) · Denmark (1) · Germany (1)
Aileen Chang, MD (1) · Allison McGeer, MD (1) · Luis Martinez-Lemus, PhD (1) · Michael Boeckh, MD (1) · Qingyu Xiu, MD (1) · Sasithon Pukrittayakamee, MD (1)
PMID 21072246, PMID 22264308, PMID 23264438, PMID 25470818, PMID 28094141, PMID 28698321, PMID 30170561, PMID 36202198, PMID 37801046, PMID 42520824
2008 (1), N01AO50042 (1)